News

[ASNO 2024] Abstracts Submission Deadline Extended

ASNO
2024-04-17
Hit 445

Can't see this email? Click here.

Abstracts Submission Deadline Extended

The deadline for abstract submissions has been extended due to overwhelming responses. Don't miss this chance to contribute to the constantly growing repository of knowledge in the field of Neuro-Oncology.

Abstracts Timeline

* Submission deadline: 10 April 2024, 12.00pm (SGT / GMT+8)

(Deadline extended to 23 April 2024)

Note: Abstracts received after will not be considered.

* Announcement of results: 10 May 2024

* Confirmation by authors (through registration): 31 July 2024

Abstracts Tracks

Submissions are welcome in the following categories:

Track 1: Neurosurgery (brain)

Track 2: Spinal Surgery (Neurosurgery and Orthopedic Surgery)

Track 3: Patient advocacy and education

Track 4: Diagnostic neuro-radiology

Track 5: Neuro-pathology

Track 6: Radiation neuro-oncology

Track 7: Medical neuro-oncology

Track 8: Pediatric neuro-oncology

Track 9: Benign tumours (brain/spine)

Track 10: Functional brain disorders

Track 11: Basic research

Track 12: Translational research

Track 13 : Clinical research

Track 14: Nursing and allied health

Track 15: Supportive care

Track 16: Survivorship

Track 17: Case series

The Organising Committee invites participants to submit abstracts of original and unpublished works related to Neuro-Oncology. Abstracts presented at other conferences but has not been published as full manuscripts can be submitted.

Submit Now

Connect with us on LinkedIn for more updates:

www.ssno.sg/asno2024

List

Lecture 1	Updates on the management of low grade gliomas (20 mins. + 5 mins. Q&A)
Julette Batara St. Luke’s Medical Center, The Philippines
Lecture 2	Biomarkers for glioblastoma (20 mins. + 5 mins. Q&A)
Mitsutoshi Nakada Kanazawa University, Japan
Lecture 3	Survivals and survivorship in adolescent and young adult CNS tumor population (20 mins. + 5 mins. Q&A)
Rakesh Jalali Apollo Proton Cancer Centre, India
Lecture 4	Management of brain tumor in resource limited setting – the LMIC perspective (20 mins. + 5 mins. Q&A)
Ather Enam The Aga Khan University, Pakistan
Closing

Lecture 1	PCNSL – Current standard of care and novel therapeutic development (25 mins. + 5 mins. Q&A)
Motoo Nagane Kyorin University, Japan
Lecture 2	Vasculogenic mimicry: potential therapeutic target of glioma (25 mins. + 5 mins. Q&A)
Zhong-ping Chen Sun Yat-Sen University, China
Lecture 3	The QOL and survivorships in childhood survivors of brain tumor (25 mins. + 5 mins. Q&A)
Hsiu-Ju Yen Taipei Veterans General Hospital, Taiwan
Lecture 4	Challenges in risk stratification of medulloblastoma in molecular era (25 mins. + 5 mins. Q&A)
Ji Won Lee Sungkyunkwan University, Korea
Closing Address
Yong-Kil Hong President of WFNOS

ASNO

News

[ASNO 2024] Abstracts Submission Deadline Extended

Abstracts Submission Deadline Extended

Abstracts Timeline

Abstracts Tracks

Connect with us on LinkedIn for more updates:

Program

1^ST ASNO Webinar

Introduction

Welcome Address

Session: Updates in Neuro-Oncology

1^st ASNO Webinar

Program

2^nd ASNO Webinar

Introduction & Welcome Address

Session: Updates in Neuro-Oncology

2^nd ASNO Webinar

ASNO

News

[ASNO 2024] Abstracts Submission Deadline Extended

Abstracts Submission Deadline Extended

Abstracts Timeline

Abstracts Tracks

Connect with us on LinkedIn for more updates:

Program

1ST ASNO Webinar

Introduction

Welcome Address

Session: Updates in Neuro-Oncology

1st ASNO Webinar

Program

2nd ASNO Webinar

Introduction & Welcome Address

Session: Updates in Neuro-Oncology

2nd ASNO Webinar

1^ST ASNO Webinar

1^st ASNO Webinar

2^nd ASNO Webinar

2^nd ASNO Webinar